{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:18:29Z","timestamp":1783948709712,"version":"3.55.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To define how reliable the benefits of potassium citrate (KCit) for stone prevention are framing this in terms of the number needed to treat (NNT). A targeted search of PubMed\/MEDLINE, Embase, and the Cochrane Library was conducted through January 2025. For studies reporting recurrence rates in treatment and control groups, absolute risk reduction (ARR) and NNT were calculated. Two pivotal randomized trials in recurrent calcium stone formers demonstrated large ARRs with KCit or potassium\u2013magnesium citrate, lowering 3-year recurrence rates from approximately 60%\u201380% in placebo groups to 10%\u201330% with therapy. Corresponding ARRs were around 50%, yielding NNTs of approximately 2 over 3 years. Evidence is strongest for calcium oxalate disease; data for calcium phosphate and brushite stones remain limited. In uric acid and cystine stones, alkalinization is first-line therapy, although precise NNT estimates are unavailable. KCit is one of the most effective preventive pharmacotherapies in nephrolithiasis. In recurrent calcium stone formers, treating two to three patients for approximately 3 years prevents one recurrence, representing a highly favorable benefit\u2013risk profile when appropriately monitored and individualized by stone phenotype.<\/jats:p>","DOI":"10.4103\/ua.ua_36_26","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:00:10Z","timestamp":1783947610000},"page":"206-214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Potassium citrate for stone prevention \u2013 Quantifying benefit through the number needed to treat: A narrative review"],"prefix":"10.4103","volume":"18","author":[{"given":"Ali","family":"Talyshinskii","sequence":"first","affiliation":[{"name":"Department of Urology, Genome Clinic, Astana, Kazakhstan"},{"name":"Department of Urology, Central Asian Medical University, Fergana, Uzbekistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Pischetola","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Unievrsity Campus Bio-medico of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"Kamal","sequence":"additional","affiliation":[{"name":"Urology Unit, King Fahd General Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar Kumar","family":"Somani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Unievrsity Campus Bio-medico of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"R1-20260713","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00240-016-0950-1","article-title":"Effect of potassium citrate supplement on stone recurrence before or after lithotripsy: Systematic review and meta-analysis","volume":"45","author":"Carvalho","year":"2017","journal-title":"Urolithiasis"},{"key":"R2-20260713","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneph.2016.101","article-title":"Idiopathic hypercalciuria and formation of calcium renal stones","volume":"12","author":"Coe","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 1","key":"R3-20260713","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000104434","article-title":"Epidemiology and risk factors in urolithiasis","volume":"79","author":"Bartoletti","year":"2007","journal-title":"Urol Int"},{"key":"R4-20260713","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02550269","article-title":"Evolution of lithogenic urinary parameters with a low dose potassium citrate treatment","volume":"30","author":"Grases","year":"1998","journal-title":"Int Urol Nephrol"},{"key":"R5-20260713","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1172\/JCI119051","article-title":"Adenosine triphosphate citrate lyase mediates hypocitraturia in rats","volume":"98","author":"Melnick","year":"1996","journal-title":"J Clin Invest"},{"key":"R6-20260713","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9343(81)90182-0","article-title":"Changes in plasma potassium concentration during acute acid-base disturbances","volume":"71","author":"Adrogu\u00e9","year":"1981","journal-title":"Am J Med"},{"key":"R7-20260713","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-5347(17)35888-3","article-title":"Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis","volume":"150","author":"Barcelo","year":"1993","journal-title":"J Urol"},{"issue":"Suppl 16","key":"R8-20260713","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/joneph\/23.S16.S49","article-title":"Low urinary citrate: An overview","volume":"23","author":"Zacchia","year":"2010","journal-title":"J Nephrol"},{"key":"R9-20260713","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1590\/S1677-55382011000500007","article-title":"Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy","volume":"37","author":"Lojanapiwat","year":"2011","journal-title":"Int Braz J Urol"},{"key":"R10-20260713","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12018-011-9111-9","article-title":"Approach to the adult kidney stone former","volume":"10","author":"Maalouf","year":"2012","journal-title":"Clin Rev Bone Miner Metab"},{"key":"R11-20260713","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1464-410X.1996.09852.x","article-title":"Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia","volume":"78","author":"Whalley","year":"1996","journal-title":"Br J Urol"},{"key":"R12-20260713","first-page":"909","article-title":"Changes in urinary nanocrystallites in calcium oxalate stone formers before and after potassium citrate intake","volume":"8","author":"Duan","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"R13-20260713","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.msec.2013.05.049","article-title":"Property changes of urinary nanocrystallites and urine of uric acid stone formers after taking potassium citrate","volume":"33","author":"Zhang","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"R14-20260713","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.juro.2008.11.014","article-title":"Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation","volume":"181","author":"Robinson","year":"2009","journal-title":"J Urol"},{"key":"R15-20260713","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0022-5347(01)68155-2","article-title":"Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis","volume":"158","author":"Ettinger","year":"1997","journal-title":"J Urol"},{"key":"R16-20260713","first-page":"CD010057","article-title":"Citrate salts for preventing and treating calcium containing kidney stones in adults","author":"Phillips","year":"2015","journal-title":"Cochrane Database Syst Rev 2015"},{"key":"R17-20260713","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-158-7-201304020-00005","article-title":"Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline","volume":"158","author":"Fink","year":"2013","journal-title":"Ann Intern Med"},{"key":"R18-20260713","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2024.05.029","article-title":"Metabolic evaluation and recurrence prevention for urinary stone patients: An EAU guidelines update","volume":"86","author":"Skolarikos","year":"2024","journal-title":"Eur Urol"},{"key":"R19-20260713","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMcp1001011","article-title":"Calcium kidney stones","volume":"363","author":"Worcester","year":"2010","journal-title":"N Engl J Med"},{"key":"R20-20260713","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1681\/ASN.2014121223","article-title":"Effect of potassium citrate on calcium phosphate stones in a model of hypercalciuria","volume":"26","author":"Krieger","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R21-20260713","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.juro.2018.07.039","article-title":"Impact of potassium citrate versus citric acid on urinary stone risk in calcium phosphate stone formers","volume":"200","author":"Doizi","year":"2018","journal-title":"J Urol"},{"key":"R22-20260713","doi-asserted-by":"crossref","first-page":"s1084","DOI":"10.2741\/1119","article-title":"Citrate and mineral metabolism: Kidney stones and bone disease","volume":"8","author":"Caudarella","year":"2003","journal-title":"Front Biosci"},{"key":"R23-20260713","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/01.ju.0000154626.16349.d3","article-title":"The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients","volume":"173","author":"Siener","year":"2005","journal-title":"J Urol"},{"key":"R24-20260713","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.juro.2010.05.094","article-title":"Profile of the brushite stone former","volume":"184","author":"Krambeck","year":"2010","journal-title":"J Urol"},{"key":"R25-20260713","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.urology.2019.05.023","article-title":"Long-term recurrence rates in uric acid stone formers with or without medical management","volume":"131","author":"Canales","year":"2019","journal-title":"Urology"},{"key":"R26-20260713","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2257.1989.tb00189.x","article-title":"Prevention of urate nephropathy in the tumour lysis syndrome","volume":"11","author":"O'Connor","year":"1989","journal-title":"Clin Lab Haematol"},{"key":"R27-20260713","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/j.ackd.2012.07.014","article-title":"Uric acid stones and hyperuricosuria","volume":"19","author":"Mehta","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"R28-20260713","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.21037\/tau.2019.05.01","article-title":"Method of alkalization and monitoring of urinary pH for prevention of recurrent uric acid urolithiasis: A systematic review","volume":"8","author":"Kamphuis","year":"2019","journal-title":"Transl Androl Urol"},{"key":"R29-20260713","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00240-018-1090-6","article-title":"Empiric therapy for kidney stones","volume":"47","author":"Goldfarb","year":"2019","journal-title":"Urolithiasis"},{"key":"R30-20260713","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-4295(02)01725-9","article-title":"Intermittent versus continuous alkaline therapy for uric acid stones and ureteral stones of uncertain composition","volume":"60","author":"Rodman","year":"2002","journal-title":"Urology"},{"key":"R31-20260713","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002400100200","article-title":"A comparison of the effects of potassium citrate and sodium bicarbonate in the alkalinization of urine in homozygous cystinuria","volume":"29","author":"Fjellstedt","year":"2001","journal-title":"Urol Res"},{"key":"R32-20260713","doi-asserted-by":"crossref","first-page":"E347","DOI":"10.5489\/cuaj.4218","article-title":"CUA guideline on the evaluation and medical management of the kidney stone patient-2016 update","volume":"10","author":"Dion","year":"2016","journal-title":"Can Urol Assoc J"},{"key":"R33-20260713","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0022-5347(17)46963-1","article-title":"Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis","volume":"134","author":"Preminger","year":"1985","journal-title":"J Urol"},{"key":"R34-20260713","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.ackd.2018.05.007","article-title":"Incomplete distal renal tubular acidosis and kidney stones","volume":"25","author":"Fuster","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"R35-20260713","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/14656566.2019.1685979","article-title":"Established and recent developments in the pharmacological management of urolithiasis: An overview of the current treatment armamentarium","volume":"21","author":"Abou Chakra","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"R36-20260713","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0022-5347(17)37520-1","article-title":"Gastrointestinal citrate absorption in nephrolithiasis","volume":"147","author":"Fegan","year":"1992","journal-title":"J Urol"},{"key":"R37-20260713","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/j.1552-4604.1984.tb01809.x","article-title":"Augmentation of renal citrate excretion by oral potassium citrate administration: Time course, dose frequency schedule, and dose-response relationship","volume":"24","author":"Pak","year":"1984","journal-title":"J Clin Pharmacol"},{"key":"R38-20260713","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00345-019-02688-9","article-title":"Medical dissolution therapy for the treatment of uric acid nephrolithiasis","volume":"37","author":"Gridley","year":"2019","journal-title":"World J Urol"},{"key":"R39-20260713","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40620-016-0329-y","article-title":"Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: A consensus statement","volume":"29","author":"Gambaro","year":"2016","journal-title":"J Nephrol"},{"key":"R40-20260713","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2036.1998.00280.x","article-title":"Effect of potassium-magnesium citrate on upper gastrointestinal mucosa","volume":"12","author":"Gonzalez","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-20260713","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archinte.1988.00380030053012","article-title":"Potassium homeostasis in liver cirrhosis","volume":"148","author":"Decaux","year":"1988","journal-title":"Arch Intern Med"},{"key":"R42-20260713","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ckj\/sfz098","article-title":"Impact of potassium citrate on urinary risk profile, glucose and lipid metabolism of kidney stone formers in Switzerland","volume":"13","author":"Wiegand","year":"2020","journal-title":"Clin Kidney J"},{"key":"R43-20260713","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1681\/ASN.2022020147","article-title":"Effects of short-term potassium chloride supplementation in patients with CKD","volume":"33","author":"Gritter","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R44-20260713","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: A CKD prognosis consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"key":"R45-20260713","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.ajkd.2019.07.016","article-title":"Effects of sodium bicarbonate in CKD stages 3 and 4: A randomized, placebo-controlled, multicenter clinical trial","volume":"75","author":"Melamed","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R46-20260713","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ki.1989.40","article-title":"Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men","volume":"35","author":"Lemann","year":"1989","journal-title":"Kidney Int"},{"key":"R47-20260713","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ki.1986.201","article-title":"Successful management of uric acid nephrolithiasis with potassium citrate","volume":"30","author":"Pak","year":"1986","journal-title":"Kidney Int"},{"key":"R48-20260713","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2215\/CJN.05850809","article-title":"Serum potassium and outcomes in CKD","volume":"5","author":"Korgaonkar","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R49-20260713","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2215\/CJN.01520216","article-title":"Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones","volume":"11","author":"Ferraro","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R50-20260713","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1523-1755.2004.66029.x","article-title":"The effect of fruits and vegetables on urinary stone risk factors","volume":"66","author":"Meschi","year":"2004","journal-title":"Kidney Int"},{"key":"R51-20260713","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0002-9343(85)90305-5","article-title":"Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis","volume":"79","author":"Pak","year":"1985","journal-title":"Am J Med"},{"key":"R52-20260713","first-page":"1200","article-title":"Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis","volume":"173","author":"Clayman","year":"2005","journal-title":"J Urol"},{"key":"R53-20260713","first-page":"CD004754","article-title":"Pharmacological interventions for preventing complications in idiopathic hypercalciuria","author":"Escribano","year":"2009","journal-title":"Cochrane Database Syst Rev 2009"},{"key":"R54-20260713","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/089277902753716098","article-title":"Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: A randomized controlled trial","volume":"16","author":"Soyg\u00fcr","year":"2002","journal-title":"J Endourol"},{"key":"R55-20260713","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-5347(17)34858-9","article-title":"Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients","volume":"151","author":"Cicerello","year":"1994","journal-title":"J Urol"},{"key":"R56-20260713","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11255-021-02891-x","article-title":"Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?","volume":"53","author":"Mohammadi","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"R57-20260713","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-5347(05)68925-2","article-title":"The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: A midterm followup study","volume":"161","author":"Lee","year":"1999","journal-title":"J Urol"},{"key":"R58-20260713","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/bju.14991","article-title":"Evaluation of the economic burden of kidney stone disease in the UK: A retrospective cohort study with a mean follow-up of 19 years","volume":"125","author":"Geraghty","year":"2020","journal-title":"BJU Int"},{"key":"R59-20260713","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00345-024-05161-4","article-title":"Consensus statement addressing controversies and guidelines on pediatric urolithiasis","volume":"42","author":"G\u00fcven","year":"2024","journal-title":"World J Urol"}],"container-title":["Urology Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ua.ua_36_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:00:17Z","timestamp":1783947617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/ua.ua_36_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ua.ua_36_26","relation":{},"ISSN":["0974-7796","0974-7834"],"issn-type":[{"value":"0974-7796","type":"print"},{"value":"0974-7834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"2026-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}